Anti-EGFR Therapeutic Antibody (Nimotuzumab)
Recombinant humanized (from mouse) antibody expressed in CHO binding to human EGFR. Nimotuzumab is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other countries for squamous cell carcinomas of the head and neck.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-710 |
| Pricing | Inquiry |
| Host | Human |
| Target | EGFR |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | ELISA, IP, FC, FuncS, Neut, IF, IHC |
| Storage | Store at -20°C. Avoid multiple freeze/thaw cycles. |